Emerge™ H7493919112200Recalls & reported problems
Boston Scientific Corporation · PTCA Dilatation Catheter · Class 2
All models of Emerge (54)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729806691), received between Apr 27, 2022 and May 16, 2025 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Difficult to Remove” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Remove1
- Material Deformation1
- Material Integrity Problem1
- Material Rupture1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 16, 2025Difficult to Remove; Material Integrity Problem; Difficult to Remove; Material Integrity Problem
IT WAS REPORTED THAT THE BALLOON CATHETER BECAME STUCK, AND REMOVAL DIFFICULTIES OCCURRED. THE PATIENT HAD SUSPECTED HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY AND UNDERWENT A CHEMICAL ABLATION OF THE CORONARY SINUS. A 2.00MM X 12MM EMERGE BALLOON CATHETER BECAME STUCK IN THE LESION DURING THE PROCEDURE AND REMOVAL DIFFICULTIES WERE ENCOUNTERED. THE DEVICE WAS DAMAGED DURING THE CHEMICAL ABLATION PROCEDURE AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THE PATIENT WAS IN STABLE CONDITION FOLLOWING PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22040441 ↗MalfunctionNov 22, 2022Material Rupture; Material Rupture
IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. A 2.00MM X 12MM EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATION. HOWEVER, DURING INFLATION BELOW REACHING THE NOMINAL PRESSURE, THE BALLOON RUPTURED. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15845737 ↗MalfunctionApr 27, 2022Material Deformation; Material Deformation
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 04-APR-2022. IT WAS REPORTED THAT SHAFT KINK OCCURRED. THE 95% STENOSED, 10X2.00MM TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND MODERATELY CALCIFIED LEFT ANTERIOR DESCENDING ARTERY. A 2.00MM X 12MM EMERGE BALLOON CATHETER WAS ADVANCED FOR DILATATION. HOWEVER, DURING THE PROCEDURE, THE DELIVERY SHAFT WAS KINKED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AND THE PATIENT STATUS WAS STABLE. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED MARKERBAND DAMAGE. RETURNED PRODUCT CONSISTED OF AN EMERGE OTW BALLOON CATHETER. THE DEVICE WAS VISUALLY AND MICROSCOPICALLY EXAMINED. AT 96.8CM, AND 98.4CM FROM THE STRAIN RELIEF OF THE DEVICE, THE SHAFT WAS KINKED. AT 4MM FROM THE TIP OF THE DEVICE, FOR A LENGTH OF 12MM, THE GUIDEWIRE LUMEN AND DISTAL MARKERBAND WERE FLATTENED. THE FOLDS OF THE BALLOON WERE TIGHT HOWEVER, THEY WERE MANIPULATED OPEN BUT HAVE NO SIGNS OF INFLATION. PRODUCT ANALYSIS CONFIRMED THE REPORTED EVENT, AS THE SHAFT OF THE DEVICE WAS KINKED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14226814 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page